PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIABETES

An object is to provide a novel compound which has a glycogen synthase activation ability, but activates a receptor PPAR to a low degree and is highly safe. Provided is a compound represented by the following general formula (I) or a pharmaceutically acceptable salt thereof: wherein Ar1 represents a...

Full description

Saved in:
Bibliographic Details
Main Authors DOHI MIZUKI, TAKESHITA SEN, KOBAYASHI KAORI, MIYANAGA WATARU, NAKAGAWA TADAKIYO, MATSUMOTO KAYO
Format Patent
LanguageEnglish
Published 18.02.2016
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

Abstract An object is to provide a novel compound which has a glycogen synthase activation ability, but activates a receptor PPAR to a low degree and is highly safe. Provided is a compound represented by the following general formula (I) or a pharmaceutically acceptable salt thereof: wherein Ar1 represents any one of the following rings (II) and (III): wherein R2 represents an alkyl group, and R3 represents a hydrogen atom or an alkyl group, and R1 represents any one of the following substituents (IV) and (V):
AbstractList An object is to provide a novel compound which has a glycogen synthase activation ability, but activates a receptor PPAR to a low degree and is highly safe. Provided is a compound represented by the following general formula (I) or a pharmaceutically acceptable salt thereof: wherein Ar1 represents any one of the following rings (II) and (III): wherein R2 represents an alkyl group, and R3 represents a hydrogen atom or an alkyl group, and R1 represents any one of the following substituents (IV) and (V):
Author MIYANAGA WATARU
DOHI MIZUKI
MATSUMOTO KAYO
KOBAYASHI KAORI
NAKAGAWA TADAKIYO
TAKESHITA SEN
Author_xml – fullname: DOHI MIZUKI
– fullname: TAKESHITA SEN
– fullname: KOBAYASHI KAORI
– fullname: MIYANAGA WATARU
– fullname: NAKAGAWA TADAKIYO
– fullname: MATSUMOTO KAYO
BookMark eNrjYmDJy89L5WSwCPBwDPJ1dHYNDfF0dvRRcPb3DfAP9gzx9PdTcPMPUgjxcFUICXJ1DPF19QtR8HdTcPF0dHINcQ3mYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBoZmBiZmppZGjobGxKkCACFCK0A
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2016046592A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2016046592A13
IEDL.DBID EVB
IngestDate Fri Jul 19 15:59:42 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2016046592A13
Notes Application Number: US201514928409
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160218&DB=EPODOC&CC=US&NR=2016046592A1
ParticipantIDs epo_espacenet_US2016046592A1
PublicationCentury 2000
PublicationDate 20160218
PublicationDateYYYYMMDD 2016-02-18
PublicationDate_xml – month: 02
  year: 2016
  text: 20160218
  day: 18
PublicationDecade 2010
PublicationYear 2016
RelatedCompanies AJINOMOTO CO., INC
RelatedCompanies_xml – name: AJINOMOTO CO., INC
Score 3.0134928
Snippet An object is to provide a novel compound which has a glycogen synthase activation ability, but activates a receptor PPAR to a low degree and is highly safe....
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Title PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIABETES
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160218&DB=EPODOC&locale=&CC=US&NR=2016046592A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlIDSt6KlSW0fhnRpSid0LW0qextrmsFAuuEq_vsmddM97S0fcCSBy-8ud_cLwGMlnoXwRGXOCXZMbLnSVDDimcIpHWITS-CWSDseO1GB3yZk0oGPbS1MyxP63ZIjKo0SSt-b9r5e_T9iBW1u5fqpXKih5WvIB4Gx8Y4tR0OWEQwHLE2ChBqUDorcGGe_c1jHEH3lKx1oQ1oz7bP3oa5LWe2CSngKh6mSVzdn0JF1D47p9u-1HhzFm5C3am60b30Obhr5WexTVnDNYoBoEqdJPtKPTEg5c4hHDPGM-VwT9KMkRMHIHzLO8gt4CBmnkamWMP3b8bTId9drX0K3XtbyCpCt7oTZHLviBTu4mhNXGXREYoldUpGZV11Df5-km_3Tt3Ciuzop2XL70G0-v-SdwtymvG-P6gdFon7S
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFH-MKc6bTsXp1IDSW9GypOsOQ9o0pdV1LWsqu40tbUGQbriK_75J3XSn3UIePF4C7zvvF4CHTDwJMRCZXhBs6tiwcl26kYEuzIVJesQQuAbSDsemn-KXKZk24GM7C1PjhH7X4IhSo4TU96q216v_IpZbv61cPy7e5dby2eNDV9tkx4apXJbmOkMWR25ENUqHaaKNJ780rHqItsyVDvoKn1cFT2-OmktZ7ToV7wQOY8mvrE6hkZdtaNHt32ttOAo3LW-53Gjf-gys2LcnoU1ZyhWKAaJRGEdJoIpMSCZziPsM8QmzuQLoR5GH3MB2GGfJOdx7jFNflyLM_k48S5NdeXsX0CyXZX4JqCdtwrzAluhjE2cFsWRAR3KcY4tkZD7IOtDdx-lqP_kOWj4PR7NRMH69hmNFUg-UDasLzerzK7-R_rda3NbX9gNcOoG_
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PHARMACEUTICAL+COMPOSITION+FOR+THE+TREATMENT+OF+DIABETES&rft.inventor=DOHI+MIZUKI&rft.inventor=TAKESHITA+SEN&rft.inventor=KOBAYASHI+KAORI&rft.inventor=MIYANAGA+WATARU&rft.inventor=NAKAGAWA+TADAKIYO&rft.inventor=MATSUMOTO+KAYO&rft.date=2016-02-18&rft.externalDBID=A1&rft.externalDocID=US2016046592A1